The AIDS and Cancer Specimen (ACSR), a biorepository of specimens collected from persons living with HIV (PLWH) has today (December 12) announced it is using software from Proscia that can provide near real-time access to pathology data to investigators...
Using a combination of pre-existing HIV drugs, a medicine for HIV-negative people taken before sex has reduced the chances of getting the virus by 86%.
As generic competition looms, Gilead donates 2.4 million bottles of Truvada to the CDC to aid in the center’s fight against the HIV epidemic in the US.
Sangamo Biosciences and Sigma-Aldrich have licensed their zinc
finger nuclease (ZFN) technology to Roche to enable the pharma
giant to develop cell lines and transgenic animals.
A naturally occurring molecule helps protect the immune system from
being destroyed by HIV and could open up a new way of fighting the
effects of the virus, according to new research.
Scientists have devised a way of using live' bacteria in yoghurt to
deliver therapeutics that can prevent HIV infection, potentially
opening up a new avenue for probiotic dairy to play a more
prominent role in drug delivery.
Scientists from the US have discovered that compounds secreted by
frog skin could be used as a successful treatment in the fight
against HIV infection, which if developed further, could form an
effective pharmaceutical treatment.
GlaxoSmithKline has halted clinical trials of its first-in-class
HIV drug after cases of hepatotoxicity was discovered in
treatment-naïve patients. The setback does not mean the end of
development for this drug candidate but suggests...
ViroLogic, announced the signing of a multi-year, $4.8 million (€4
million) service agreement with Schering-Plough Research Institute,
to use ViroLogic's novel HIV resistance testing technology to
support Schering-Plough's...
VIRxSYS report the results of its latest clinical trial, testing
VRX496, a HIV-derived lentiviral vector that could represent a
novel HIV gene therapy. The trial results also showed patients with
multiple-drug resistant HIV responding...
The first documented case of drug resistant HIV has prompted calls
to step up HIV drug research after the victim developed full-blown
AIDS in just three months.
A new family of drugs specifically designed to inhibit nuclear
import of integrase, blocking viral replication of human
immunodeficiency virus type 1 (HIV-1) infected cells suggests an
approach that could be effective against drug...